Skip to content
healthcare.dev

Nevirapine

NDC 0378-4050, nevirapine, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
0378-4050
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA202523
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4050 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEVIRAPINE200 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 3A Inducers [MoA]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
0378-4050-910037840509160 TABLET in 1 BOTTLE, PLASTIC (0378-4050-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c6e93829-7024-48f6-8023-da6ff27dfc0a
  • NADAC price for package 00378405091

    GET /v1/drugs/nadac/00378405091

Use it

Look up 0378-4050 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0378-4050 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0378-4050. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.